doi: 10.1016/s0196-9781(00)00252-7.
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
Affiliations
- PMID: 10998549
- DOI: 10.1016/s0196-9781(00)00252-7
Item in Clipboard
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
Peptides.
2000 Jul.
Abstract
The nociceptin/orphanin FQ (N/OFQ) receptor (e.g. the human ortholog ORL1) has been shown to be pharmacologically distinct from classic opioid receptors. Recently, we have identified buprenorphine as a full ORL1 agonist using a reporter gene assay. For further functional analysis, buprenorphine's effects on ORL1 receptors were investigated using a K(+) channel (GIRK1) assay in Xenopus oocytes and GTPgammaS assay in CHO-K1 membrane preparations. In both assays, buprenorphine behaved as a partial agonist compared to nociceptin itself. The N/OFQ agonism of buprenorphine might contribute to actions of buprenorphine in pain models in vivo beside its mu- or kappa-opioid receptor mediated effects.
Similar articles
-
Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.J Pharmacol Exp Ther. 2001 May;297(2):688-95. J Pharmacol Exp Ther. 2001. PMID: 11303059
-
N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.J Pept Res. 2003 Nov;62(5):191-8. doi: 10.1034/j.1399-3011.2003.00077.x. J Pept Res. 2003. PMID: 14531842
-
Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.J Chem Neuroanat. 2003 Jul;25(4):233-47. doi: 10.1016/s0891-0618(03)00032-2. J Chem Neuroanat. 2003. PMID: 12842269
-
Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray.J Biomed Sci. 2000 May-Jun;7(3):232-40. doi: 10.1007/BF02255471. J Biomed Sci. 2000. PMID: 10810242 Review.
-
Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.Vitam Horm. 2015;97:1-55. doi: 10.1016/bs.vh.2014.10.001. Epub 2015 Jan 14. Vitam Horm. 2015. PMID: 25677767 Review.
Cited by
-
Evaluation of Candidates for Systemic Analgesia and General Anesthesia in the Emerging Model Cephalopod, Euprymna berryi.Biology (Basel). 2023 Jan 28;12(2):201. doi: 10.3390/biology12020201. Biology (Basel). 2023. PMID: 36829480 Free PMC article.
-
The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine.Neuroscience. 2008 Aug 26;155(3):597-602. doi: 10.1016/j.neuroscience.2008.06.027. Epub 2008 Jun 19. Neuroscience. 2008. PMID: 18634857 Free PMC article.
-
Effectiveness of two extended-release buprenorphine formulations during postoperative period in neonatal rats.PLoS One. 2022 Oct 17;17(10):e0276327. doi: 10.1371/journal.pone.0276327. eCollection 2022. PLoS One. 2022. PMID: 36251720 Free PMC article.
-
Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.RNA. 2004 Mar;10(3):516-27. doi: 10.1261/rna.5186504. RNA. 2004. PMID: 14970396 Free PMC article.
-
Transdermal buprenorphine - a critical appraisal of its role in pain management.J Pain Res. 2009 Sep 15;2:117-34. doi: 10.2147/jpr.s6503. J Pain Res. 2009. PMID: 21197300 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
